A Trial of Albuterol Should Still be Considered for Children with Severe Bronchiolitis —Reply

In Reply We read with interest Horvat and Pelletier ’s commentary and thank them for their interest in our trial, which deimplemented non–evidence-based treatment of infants with bronchiolitis, particularly albuterol use in intervention hospitals. The authors disagreed that compliance with deimplementing non–evidence-based pharmacotherapies sho uld be 100%, advocating for trials of albuterol in children with severe bronchiolitis.
Source: JAMA Pediatrics - Category: Pediatrics Source Type: research